De-risking the Development of Tomorrow’s Medicines with Advancing Analytical Characterization Capabilities

Home | Knowledge Center | Resource Library | De-risking the Development of Tomorrow’s Medicines with Advancing Analytical Characterization Capabilities

Jason Barker, PhD., Director of Analytical & Formulation Development at FUJIFILM Diosynth Biotechnologies explores the advancements in mass spectrometry, biophysical characterization, automated sample preparation, and high-throughput analytics that are crucial for achieving these goals.

In this webinar Jason provides three key takeaways:

  1. The rise of complex biotherapeutics necessitates advanced analytical techniques, moving beyond the traditional “platform” methods.
  2. Evaluating a biotherapeutic’s “personality” throughout development is crucial, offering benefits beyond the data required for regulatory submissions.
  3. Gaining comprehensive product knowledge empowers efficient and robust process development by informing key decisions.